The global single-cell sequencing market is expected to reach USD 3,230.6 Million by 2027, according to a new report by Emergen Research. Single-cell sequencing finds widespread use in resolving heterogeneity of tumor, reconstruction of cancer cell evolutionary courses, and identification of rare sub-clones, thereby providing a promising technique for addressing resistance to drugs.
To get leading market solutions, visit the link below:
https://www.emergenresearch.co....m/industry-report/si